This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Medtronic unveils outcomes of the largest multi-centric prospective stroke registry on mechanical thrombectomy in India (PRAAN) ...

An ordinal score incorporating eight independent binary clinical variables shows good performance for predicting seizure ...

Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...

Like with athletics, surgery is a field in which technology offers new ways to gain deeper insights into performance and ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

For adolescents, weight loss after bariatric surgery was durable out to 10 years, data from the Teen Longitudinal Assessment ...